# Neuralink Launches First European Clinical Trial (GB-PRIME) in the UK

> clinical trial · REPORTED · 2025-07-31

Neuralink launched its GB-PRIME study in Great Britain on July 31, 2025, partnering with University College London Hospitals and Newcastle upon Tyne Hospitals to implant up to seven patients with severe paralysis. The UK became the first European country to host a Neuralink brain-computer interface study, approved by the Medicines and Healthcare products Regulatory Agency.

About Neuralink: Neuralink develops fully implantable brain-computer interfaces (BCIs) intended to help people with paralysis and neurological conditions control digital devices using only their thoughts.

- Company: Neuralink
- Sector: medical_device
- Primary source: https://www.bloomberg.com/news/articles/2025-07-31/neuralink-launches-clinical-trial-in-britain-to-test-brain-chip

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.